Overexpression of HER3 has been reported in breast, ovarian, pancreatic and gastric cancers, and is significantly associated with cancer malignancy [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]. Here, ERBB3 is linked to gastric cancer.